Brief: Prokidney Corp Enters Open Market Sale Agreement With Jefferies
29/10/2026 22:35
BRIEF-Prokidney Corp Enters Open Market Sale Agreement With Jefferies Oct 29 (Reuters) - Prokidney Corp PROK.O:
PROKIDNEY CORP - ENTERS OPEN MARKET SALE AGREEMENT WITH JEFFERIES ON OCT 29, 2026 - SEC FILING
PROKIDNEY CORP - JEFFERIES ENTITLED TO UP TO 3.0% OF GROSS OFFERING PROCEEDS - SEC FILING
PROKIDNEY CORP - MAY OFFER SHARES UP TO $200 MILLION AGGREGATE OFFERING PRICE UNDER SALES AGREEMENT - SEC FILING
Further company coverage: PROK.O
(((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on Prokidney
See all newsProkidney Corp reports results for the quarter ended September 30 - Earnings Summary
ProKidney Q3 loss widens on higher R&D costs
Brief: ProKidney Q3 Operating Income USD -53.758 Million
Brief: Prokidney Corp Enters Open Market Sale Agreement With Jefferies
Cell therapy developer ProKidney's Q2 operating loss widens as trial costs rise